www.newsmax.com
New Novo Obesity Drug More Effective Than Wegovy
Novo Nordisk said on Thursday early trial data for its highly anticipated experimental obesity drug amycretin showed a higher weight loss compared with its popular Wegovy treatment‚ sending its shares to new record highs. A Phase I trial of amycretin pill version showed...